Ausgabe 1/2013
Inhalt (12 Artikel)
Primary and Secondary Antifungal Prophylaxis in the Immunocompromised Child: Where do we Stand?
Charalampos Dokos, Fani Athanassiadou
The Role of Biomarkers for Diagnosis of and Therapeutic Decisions Related to Invasive Aspergillosis in Children
Brian T. Fisher
1–3 β-D-glucan: From Diagnosis to Prognosis
Eric P. Richards, Shahrzad Mohammadi, Graeme N. Forrest
How I Treat Blastomycosis
Laurie A. Proia
How I Treat Coccidioidomycosis
Shobha Sharma, George R. Thompson III
How I Treat Histoplasmosis
Ricardo M. La Hoz, James E. Loyd, L. Joseph Wheat, John W. Baddley
Penicillium marneffei Infection in Immunocompromised Host
Maria Chitasombat, Khuanchai Supparatpinyo
Advancing the Field: Evidence for New Management Strategies in Invasive Fungal Infections
C. Orla Morrissey
EUCAST and CLSI: Working Together Towards a Harmonized Method for Antifungal Susceptibility Testing
Ana Espinel-Ingroff, Manuel Cuenca-Estrella, Emilia Cantón
Animal Models In Mycology: What Have We Learned Over The Past 30 Years
William R. Kirkpatrick, Nathan P. Wiederhold, Laura K. Najvar, Thomas F. Patterson
Are Echinocandins Better Than Azoles for Invasive Candidiasis?
Sanjay G. Revankar, Jack D. Sobel
Invasive Fungal Infections: A Continuing Challenge Report from the 17th International Symposium on Infections in the Immunocompromised Host, Genoa, Italy, 24–27 July 2012
Monica A. Slavin, Liz McNeil Grist